PubMed COVID-19 Clinical Care

CONCLUSIONS: Results suggest that the BNT162b2 COVID-19 vaccine is >90% effective in preventing SARS-CoV-2 infection in the 3 weeks after the second vaccination, irrespective of iron-deficiency status. These findings support the use of the vaccine in

No abstract

I analyze the human life-economic loss dilemma (HELD) trade-off between saving lives ad saving economic activities during the emergency period of Covid 19 pandemic. A new concept labeled HELD Curve, not addressed in the literature so far, is proposed

CONCLUSION: College graduates' negative experiences came from multiple levels, and they use multiple coping strategies to deal with the challenges. Our results provide important guidance for researchers and policymakers to design effective and

CONCLUSIONS: This is the first case series about moderate to severe hepatitis in COVID-19 neonatal patients via horizontal transmission. Besides fever and respiratory symptoms, the clinical doctor should pay much attention to evaluating the risk of

This study presents the design and characterization of a highly Q-Factor and ultrasensitive THz refractive-index-based metamaterial biosensor for detecting coronaviruses at electronic infusion device (EID) concentrations 0.01 and 1000. The proposed

One of the predominant symptoms of the COVID-19 virus is the complete (anosmia) or partial (hyposmia) loss of smell. Anosmia may be a critical neurocognitive symptom because there is an empirically demonstrated association of anosmia with

Mental health issues, especially depressive disorders, are major burdens to the health care systems. This has been more pronounced since the onset of the COVID-19 pandemic. Selective serotonin reuptake inhibitors (SSRIs) are often prescribed for

INTRODUCTION: The nonstructural protein 12 (NSP12) of the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has a high sequence identity with common cold coronaviruses (CCC).

Starting from compound 5 (CCF0058981), a structure-based optimization of the P1 subsite was performed against the severe acute respiratory syndrome coronavirus (SARS-CoV-2) main protease (3CL ^(pro) ). Inhibitor 5 and the compounds disclosed bind to